COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes.

"Author disclosures are available with the text of this article at www.atsjournals.org."

"Supported by Career Development Award Number IK2 BX004886 from the U.S. Department of Veterans Affairs Biomedical Laboratory R&D Service (W.B.); the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Numbers K23 HL129987 (G.D.K.), K23GM122069 (F.A.S.), P01HL114453 (P.R., J.S.L., B.J.M.), and R01 HL136143, R01 HL142084, and K24 HL143285 (J.S.L.); the University of Pittsburgh Clinical and Translational Science Institute COVID-19 Pilot Grant Program (G.D.K.); the University of Pittsburgh Medical Center Immune Therapy and Transplant Center (A.M.); the University of Pittsburgh Medical Center (D.A.A.V.); and a Hillman Postdoctoral Fellowship for Innovative Cancer Research (A.R.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, Department of Veterans Affairs, or any other sponsoring agency."